Literature DB >> 19847195

The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.

R A de Boer1, F M A C Martens, I Kuipers, F Boomsma, F L J Visseren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19847195     DOI： 10.1038/jhh.2009.84

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  4 in total

Review 1.  PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Authors:  Janice V Huang; Clifford R Greyson; Gregory G Schwartz
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

2.  The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.

Authors:  Zhi-qiang Pan; Ding Xie; Vivek Choudhary; Mutsa Seremwe; Ying-Ying Tsai; Lawrence Olala; Xunsheng Chen; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2014-07-17       Impact factor: 4.102

3.  Identification of a proliferator-activated receptor-γ antagonist for the treatment of type 2 diabetes mellitus.

Authors:  Ren Wang; Lihua Dai; Jinjin Chen
Journal:  Exp Ther Med       Date:  2014-12-01       Impact factor: 2.447

4.  Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients.

Authors:  Ji-Hung Wang; Chung-Jen Lee; Jen-Che Hsieh; Yu-Chih Chen; Bang-Gee Hsu
Journal:  Diabetol Metab Syndr       Date:  2013-04-08       Impact factor: 3.320
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.